News

Relmada Therapeutics Prepares for Q4 2024 Financial Discussion

Relmada Therapeutics Prepares for Q4 2024 Financial Discussion

Relmada Therapeutics to Discuss Fourth Quarter Financials

Relmada Therapeutics, Inc. (Nasdaq: RLMD), a pioneering biotechnology firm, is set to host an important conference call and webcast to share their fourth-quarter financial results and recent advancements in their programs. This event will take place on a day that is significant for the company as they reflect on their progress and outline future directions.

Conference Call and Webcast Details

The conference call is scheduled for a Thursday afternoon, an ideal time for investors and stakeholders to join and hear directly from the company's leadership. The call is expected to start promptly at 4:30 PM Eastern Time.

How to Participate

For those who wish to dial in, there are specific numbers available. Participants in the United States can call 1-877-407-0792, while international attendees can reach the conference at 1-201-689-8263. The conference ID for this event is 13751458, ensuring your entry into the call.

Webcast Access

For convenient access to the discussion, a webcast will also be available. Participants can easily join online to hear the live presentation and reflect on the opportunities presented by the company.

Webcast Replay Availability

For those unable to attend the live discussion, a replay of the webcast will be accessible afterward in the Investors section of Relmada's official website. This feature allows stakeholders to stay updated on the company's performance and strategic plans.

Company Overview: Relmada Therapeutics

Relmada Therapeutics is dedicated to transforming the landscape of treatment options for patients. As a clinical-stage biotech organization, they focus on developing groundbreaking therapies aimed at providing significant clinical benefits to those in need.

Innovative Programs Under Development

One of the company's lead investigational programs, NDV-01, is currently in a Phase 2 study targeting High-Grade Non-Muscle Invasive Bladder Cancer. This program represents a crucial step in finding effective treatments for patients suffering from this condition, showcasing Relmada's commitment to innovation.

Advancements in Compulsion-Related Disorders

In addition, preparations are in progress to advance Relmada’s investigational program, sepranolone. This program is ready to enter Phase 2b trials and focuses on compulsion-related disorders, including Tourette’s Syndrome. These efforts illustrate the company's proactive approach in addressing various challenging health issues.

Stay Informed with Relmada Therapeutics

The company encourages everyone to stay informed about their progress by regularly visiting their website and accessing investor resources. This way, stakeholders can keep abreast of new developments and planned releases that may impact their investments.

Contacting Relmada Therapeutics

If you have any inquiries, they have dedicated contacts for investor relations and media inquiries. Brian Ritchie from LifeSci Advisors is the primary contact for investor-related questions, reachable via email. Additionally, media inquiries can be directed to the corporate communications team via another dedicated email.

Frequently Asked Questions

What time is the fourth-quarter financial results conference call?

The conference call will take place at 4:30 PM ET on Thursday.

How can I access the webcast of the conference call?

You can access the webcast through the official Relmada Therapeutics website.

What is Relmada Therapeutics focusing on in their programs?

Relmada focuses on innovative therapies for conditions such as High-Grade Non-Muscle Invasive Bladder Cancer and compulsion-related disorders.

Who can I contact for investor-related inquiries?

Brian Ritchie at LifeSci Advisors is the contact for investor inquiries.

Where can I find more information about Relmada Therapeutics?

More information can be found on Relmada Therapeutics' official website, where updates and resources are regularly posted.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

HIMS Faces Class Action Over Alleged Privacy Violations

Updated Category News Views 15

Got a thing for drama in the world of stocks? Well, listen up. Hims & Hers Health, Inc., the darling of digital health on the NYSE, is up to its eyeballs in a fresh securities fraud class action lawsuit over some seriously questionable practices. If you got skin in this game with HIMS between August 4, 2025, and July 29, 2026, you've got a deadline staring you down:...

Continue Reading
Quaker Houghton Propels Forward with Q3 2026 Gains

Updated Category News Views 39

Quaker Houghton's Strategy Yields Positive Q3 2026 Results Imagine getting through another quarter against global economic headwinds and coming out profitable. That’s exactly what Quaker Houghton (NYSE:KWR) pulled off in Q3 2026. Their net sales jumped to a solid $544.5 million, marking a 10% increase from the same quarter last year. Not bad for a company that had its...

Continue Reading
Picturing Grief: Scoville's Visual Journey in Loss

Updated Category News Views 67

Let Images Speak the Unspeakable So, here's the deal: grief isn't something you can just wrap up in a neat little package of words. It's jagged, messy—and for many, untouchable by a traditional self-help roadmap. Enter Picturing Grief, the book by Michelle Scoville that smashes the mold with its arresting mix of imagery and reflection. Freshly on the scene courtesy of...

Continue Reading
BAILOR Welcomes Co-Founder Bob Bailor to Coach Academy

Updated Category News Views 32

A New Chapter for a Seasoned Entrepreneur There's a certain irony in a seasoned business vet stepping into a new role at his own daughter's company, and that's exactly what's unfolding with the Bailors. Huntsville's own BAILOR isn't just another growth strategy company; it's the embodiment of a father-daughter dream team. After years as the ordinary head honcho, Bob...

Continue Reading
Hikvision Unveils AI Solutions Tailored for SMB Growth

Updated Category News Views 0

Technology Geared for Practical Application Look, I’ve been around the tech block a few times, and Hikvision's latest shindig over in Hangzhou is causing a stir. Their third annual SMB gala isn't just lip service. We're talking about AI innovations meant to scratch where it actually itches for small businesses. The name of the game here is practical value. And yeah,...

Continue Reading
Foxconn Spotlights AI Advancements at Tech Day 2026

Updated Category News Views 68

Foxconn's Bold Step into AI Infrastructure Foxconn, the tech giant that most folks recognize for its sheer prowess in electronics manufacturing, isn't just idling on past laurels. During the 7th annual Hon Hai Tech Day 2026, it was a showcase of fireworks that left attendees buzzing about the future of AI infrastructure and beyond. And when Foxconn says it's transforming,...

Continue Reading
Hisense's RGB MiniLED TVs: Redefining Halloween Viewing

Updated Category News Views 20

A New Dimension to Halloween's Visuals You ever notice how some TVs just can’t do justice to a Halloween flick? It’s all about the details—those rich, spooky colors and the perfectly balanced light and shadow. The nuance in the shadowy folds of a cape or the eerie glow of a lantern is crucial. Hisense's RGB MiniLED technology is showing up just in time to rescue...

Continue Reading
ACACIA's Big Move with Bel-Mac and Seashore: Will It Pay Off?

Updated Category News Views 135

A New Powerhouse in Roofing Services? Take a seat, folks—we're talking about a regional shakeup in the world of roofing and exterior building. ACACIA Exterior Building Group, based out of Alexandria, Virginia, just tightened its grip on the Mid-Atlantic and Gulf Coast markets by investing in Bel-Mac Roofing and Seashore Construction. This ain't just your run-of-the-mill...

Continue Reading
Home Selling in Henderson County: Tips from Experts

Updated Category News Views 0

An Insider's View on Selling Homes in Henderson County Ace up, folks—selling a home isn't child's play. Courtney Robertson, a seasoned real estate expert, lays out the bare truth about what sellers need to know when putting their property on the market in Henderson County, Texas. This isn’t just about slapping on paint and praying for buyers. Nope, there's a lot more...

Continue Reading
Are Shareholder Interests at Risk in These Deals?

Updated Category News Views 12

Potential Pitfalls in Pending Transactions In the tangled world of corporate deals, not every handshake benefits everyone around the table. This time, it's Surgery Partners, Range Resources, and Penske Automotive Group finding themselves under legal scrutiny. We'll dig into why Nasdaqq:SGRY, Nyse:RRC, and Nyse:PAG, might have some explaining to do. Whose Pockets Are...

Continue Reading

Top 5 Most Recently Viewed Articles

Duke Energy Leads Restoration Efforts Post-Hurricane Helene

Updated Category News Views 111

Duke Energy mobilized a massive workforce to restore power to over 1.1 million customers after Hurricane Helene wreaked havoc across the Carolinas. As of the last reports, around 904,000 customers remained without power—508,000 in South Carolina and 396,000 in North Carolina—most of them stranded in mountainous regions where access is nearly impossible. Power...

Continue Reading
Replenish Nutrients' Ambitious U.S. Expansion Plan Unveiled

Updated Category News Views 172

The Vision Behind Replenish Nutrients’ Growth Replenish Nutrients is more than just a agricultural company; it is on a mission to revolutionize the fertilizer industry. The firm is transforming from a regional player into a global force in regenerative agriculture. Their journey begins with innovative micro-nutrient fertilizers designed to not only enhance plant growth...

Continue Reading
Zai Lab Advances Cancer Treatment with ZL-1310 Orphan Designation

Updated Category News Views 468

Zai Lab's ZL-1310 Receives Orphan Drug Designation Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) has achieved a significant milestone in the fight against small cell lung cancer (SCLC) with the recent announcement that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to ZL-1310, an innovative drug targeting DLL3, a protein overexpressed...

Continue Reading
Payfare's Strategic Acquisition by Fiserv Promises Growth

Updated Category News Views 147

Payfare's Exciting New Chapter with Fiserv Payfare Inc. is set to embark on an exciting new chapter following its announcement of a definitive agreement with Fiserv, Inc. This partnership comes at a time when Payfare, a leader in Earned Wage Access (EWA), is constantly innovating and creating digital banking solutions for workforces. The agreement indicates a strong...

Continue Reading
Uniting Earth Through Art and Philosophy: The Saturn Prize

Updated Category News Views 103

The Birth of The Saturn Prize Initiative In a refreshing twist on traditional awards, the Saturn Prize emerges from an inspiring vision. The Angels from the Planet Saturn have created a unique interplanetary honor meant to bring people together through creativity rather than conflict. This award offers a life-extending gift of up to 300 years to the individual who can...

Continue Reading